Literature DB >> 6296088

Specific receptor sites for pyridoxal 5'-phosphate and pyridoxal 5'-deoxymethylenephosphonate at the alpha and beta NH2-terminal regions of hemoglobin.

K D Schnackerz, R E Benesch, S Kwong, R Benesch, E J Helmreich.   

Abstract

hemoglobins have been prepared which are substituted with pyridoxal 5'-phosphate or pyridoxal 5'-deoxymethylenephosphonate at both NH2-terminal amino groups of either the alpha or the beta chains. 31P NMR titration curves of the 5' side chain show a substantial decrease in acid strength in hemoglobins pyridoxylated at the alpha chains and the reverse effect in the hemoglobins labeled in the beta chains. These changes can readily be explained by the interaction of the 5' side chains with surrounding residues which provide specific binding sites for the monoanion at the alpha chain termini and for the dianion in the case of the beta chains. Since the proportion of monoanion is at lest ten times greater for pyridoxal 5'-deoxymethylenephosphonate than for pyridoxal 5'-phosphate at neutral pH, the phosphonate reacts preferentially with the alpha chain NH2-terminal amino groups and the phosphate with the beta chain ones.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6296088

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Improvement of oxygen-carrying properties of human hemoglobin by chemical modification with a benzene hexacarboxylate-monosubstituted polyoxyethylene.

Authors:  E Dellacherie; M Léonard
Journal:  J Protein Chem       Date:  1991-02

2.  Characterization of the binding of the anti-sickling compound, BW12C, to haemoglobin.

Authors:  M Merrett; D K Stammers; R D White; R Wootton; G Kneen
Journal:  Biochem J       Date:  1986-10-15       Impact factor: 3.857

3.  Compartmentalization of pyridoxal-5'-phosphate during the acute phase of myocardial infarction.

Authors:  W J Vermaak; H C Barnard; E M Van Dalen; G M Potgieter; H Van Jaarsveld; S J Myburgh
Journal:  Klin Wochenschr       Date:  1988-05-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.